Skip to content
value.today

Freenome, Inc.: financial analysis

Ratios worked out from 2 fiscal years of Freenome, Inc.'s statements, compared with 87 companies in Diagnostics and Research.

Return on equity, 2025
0.4%
Diagnostics and Research: -5.4%

Freenome, Inc. scorecard#

Passes 2 of the 6 checks that could be worked out. Fiscal year 2025; market cap of Oct 2, 2026.

  • Valuation0 of 3
    • ✗P/E below its peers' median2076.0×P/E 2076.0× against Diagnostics and Research's median of 35.5×.
    • ✗Price to book below its peers' median17.4×Price to book 17.4× against Diagnostics and Research's median of 3.7×.
    • –Price to sales below its peers' medianNo Price to sales on file.
    • –Free cash flow yield above 5%No free cash flow yield on file.
    • ✗Earnings yield above the 10-year Treasury yield0.0%Earnings yield 0.0% against the 10-year Treasury's 5.15% on 2026-11-13.
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growthnot known
    • –Revenue grew in the newest yearRevenue of the year before is not on file.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
    • –Net income higher than five years earlierNet income of five years earlier is not on file.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability1 of 2
    • ✓Profitable in the newest year$1 MNet income $1 M in fiscal 2025.
    • –Profitable in each of the last five yearsFive years of net income are not on file.
    • –Operating margin above its peers' medianNo operating margin on file.
    • ✗Return on equity above 15%0.4%0.4% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health1 of 1
    • ✓Short-term assets cover short-term liabilities5.6×Current ratio 5.59 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returnsnot known
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.

Worked out from the statements as filed (sec), the medians of Diagnostics and Research, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

What the 2025 statements show#

Each line is an observation with its numbers, not a judgement of the company.

Worth a look

  • Only -102% of net income arrived as cash from operations.

Profitability#

Freenome, Inc.: profitability by fiscal year
Fiscal yearTrend20252024Median of peersAhead of
Return on equity0.4%—-5.4%58%
Return on assets0.3%—-7.1%62%

Financial strength#

Freenome, Inc.: financial strength by fiscal year
Fiscal yearTrend20252024Median of peersAhead of
Current ratio5.59×5.90×1.97×83%
Equity share of assets19.8%343.2%51.8%17%

Cash#

Freenome, Inc.: cash by fiscal year
Fiscal yearTrend20252024Median of peersAhead of
Cash conversion-102.4%—169.7%3%

How each figure is worked out#

Return on equity
Net income as a share of shareholders' equity (the average of the start and the end of the year). Not given when equity is negative.
Return on assets
Net income as a share of total assets (average of the year).
Current ratio
Assets due within a year divided by liabilities due within a year.
Equity share of assets
Shareholders' equity as a share of total assets.
Cash conversion
Cash from operations as a share of net income. Only when the year was profitable.

Source: Freenome, Inc.'s statements: annual reports filed with the SEC. Arithmetic on reported figures, in US dollars; nothing is estimated. A figure is blank when a line it needs is not in the statements on file, and left out when the result cannot be right (a margin from next to no revenue). "Ahead of" is the share of the 87 companies in Diagnostics and Research that Freenome, Inc. is better than on that figure, using each company's newest fiscal year; yields use today's market value. Medians for every industry · Back to Freenome, Inc.